XBIO - Xenetic Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue-7,5853,000-
Cost of Revenue-156.119--
Gross Profit-7,428.8813,000-
Operating Expenses
Research Development2,783.9523,9604,137.8143,299.141
Selling General and Administrative4,492.3756,437.6436,792.7866,522.875
Non Recurring----
Others----
Total Operating Expenses7,276.32710,553.76210,930.69,822.016
Operating Income or Loss-7,276.327-2,968.762-7,930.6-9,822.016
Income from Continuing Operations
Total Other Income/Expenses Net-24.131-626.37-46,275.506-2,685.455
Earnings Before Interest and Taxes-7,276.327-2,968.762-7,930.6-9,822.016
Interest Expense--1.818-729.572-266.999
Income Before Tax-7,300.458-3,595.132-54,206.106-12,507.471
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-7,300.458-3,595.132-54,206.106-12,507.471
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-7,300.458-3,595.132-54,206.106-12,507.471
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-7,300.458-3,595.132-58,241.366-12,507.471